RecruitingNot ApplicableNCT05828030

HFNC Compared With Facial Mask in Patients With Chest Trauma Patients

Noninvasive Ventilation With High Flow Nasal Cannula Compared With Facial Mask in Patients With Chest Trauma: a Randomized Controlled Study


Sponsor

National Taiwan University Hospital

Enrollment

100 participants

Start Date

Apr 26, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Guidelines for noninvasive ventilation (NIV) recommend continuous positive airway pressure in patients with thoracic trauma who remain hypoxic . However, no any suggestion was applied for high flow nasal cannula (HFNC). Therefore, Our aim was to determine whether HFNC reduces intubation in severe trauma-related hypoxemia.


Eligibility

Min Age: 20 YearsMax Age: 99 Years

Inclusion Criteria4

  • Patients who have the following condition within 72 hours of chest trauma despite receiving standard nasal cannula oxygen therapy \[≥10 L/min\], are eligible for inclusion.
  • severe hypoxemic respiratory failure \[Arterial partial pressure of oxygen (PaO2)/fraction of inspired oxygen fraction(FiO2) <300 mmHg\]
  • with a respiratory rate >25 breaths/minute and difficulty breathing, or respiratory distress
  • PaCO2 of 45 mmHg or higher (if the patient requires emergency surgery with endotracheal intubation and mechanical ventilation, the time of inclusion will be the start of the post-extubation period. (Note: For patients who receive emergency trauma surgery with endotracheal intubation and mechanical ventilation, the time of inclusion assessment will be 72 hours after extubation.)

Exclusion Criteria9

  • Patients with a Glasgow Coma Scale less than 8 or severe brain injury.
  • Patients with any contraindications to non-invasive ventilation, including acute gastrointestinal bleeding, upper airway obstruction, or hemodynamic instability.
  • Facial trauma involving skull base fractures, facial bone fractures, or orbital floor fractures.
  • Severe injuries involving the nasal sinuses.
  • Patients with cervical spine injuries.
  • Patients with increased intracranial pressure.
  • Patients with facial, nasal, or airway structural abnormalities or surgery that prevents the use of appropriate nasal cannula.
  • Patients after upper airway surgery.
  • Patients who are unable to clearly express their willingness to sign informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREhigh flow nasal cannula

the patient receives HFNC after randomization. All patients will have FiO2 started at 0.4 and titrated to maintain oxygen saturation (SpO2) ≥ 95%.

PROCEDUREOxygen mask

All patients will have FiO2 started at 0.4 and titrated to maintain oxygen saturation (SpO2) ≥ 95%.


Locations(2)

Department of Traumatology, National Taiwain University Hospital

Taipei, Taipei, Taiwan

NTUH Hsin-Chu Branch; NTUH Yun-Lin Branch

Taipei, Taiwan, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05828030


Related Trials